Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Prochlorococcus marinus Serine--tRNA ligase (serS) CSB-YP388159PZE
CSB-EP388159PZE
CSB-BP388159PZE
CSB-MP388159PZE
CSB-EP388159PZE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus 5'-nucleotidase surE (surE) CSB-YP388160PZE
CSB-EP388160PZE
CSB-BP388160PZE
CSB-MP388160PZE
CSB-EP388160PZE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus UDP-N-acetylglucosamine 1-carboxyvinyltransferase (murA) CSB-YP388161PZE
CSB-EP388161PZE
CSB-BP388161PZE
CSB-MP388161PZE
CSB-EP388161PZE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus 3-methyl-2-oxobutanoate hydroxymethyltransferase (panB) CSB-YP388162PZE
CSB-EP388162PZE
CSB-BP388162PZE
CSB-MP388162PZE
CSB-EP388162PZE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Orotidine 5'-phosphate decarboxylase (pyrF) CSB-YP388163PZE
CSB-EP388163PZE
CSB-BP388163PZE
CSB-MP388163PZE
CSB-EP388163PZE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus tRNA pseudouridine synthase B (truB) CSB-YP388164PZE
CSB-EP388164PZE
CSB-BP388164PZE
CSB-MP388164PZE
CSB-EP388164PZE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus DNA-directed RNA polymerase subunit omega (rpoZ) CSB-YP388165PZE
CSB-EP388165PZE
CSB-BP388165PZE
CSB-MP388165PZE
CSB-EP388165PZE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus ATP synthase epsilon chain (atpC) CSB-YP388166PZE
CSB-EP388166PZE
CSB-BP388166PZE
CSB-MP388166PZE
CSB-EP388166PZE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Ribosomal RNA small subunit methyltransferase G (rsmG) CSB-YP388168PZE
CSB-EP388168PZE
CSB-BP388168PZE
CSB-MP388168PZE
CSB-EP388168PZE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus DNA-directed RNA polymerase subunit beta (rpoB), partial CSB-YP388169PZE
CSB-EP388169PZE
CSB-BP388169PZE
CSB-MP388169PZE
CSB-EP388169PZE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Ribonuclease HII (rnhB) CSB-YP388170PZE
CSB-EP388170PZE
CSB-BP388170PZE
CSB-MP388170PZE
CSB-EP388170PZE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Photosystem I reaction center subunit XI (psaL), partial CSB-YP388171PZE1
CSB-EP388171PZE1
CSB-BP388171PZE1
CSB-MP388171PZE1
CSB-EP388171PZE1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus 50S ribosomal protein L15 (rplO) CSB-YP388172PZE
CSB-EP388172PZE
CSB-BP388172PZE
CSB-MP388172PZE
CSB-EP388172PZE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus 30S ribosomal protein S8 (rpsH) CSB-YP388173PZE
CSB-EP388173PZE
CSB-BP388173PZE
CSB-MP388173PZE
CSB-EP388173PZE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus 50S ribosomal protein L24 (rplX) CSB-YP388174PZE
CSB-EP388174PZE
CSB-BP388174PZE
CSB-MP388174PZE
CSB-EP388174PZE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus 50S ribosomal protein L29 (rpmC) CSB-YP388175PZE
CSB-EP388175PZE
CSB-BP388175PZE
CSB-MP388175PZE
CSB-EP388175PZE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus 50S ribosomal protein L2 (rplB) CSB-YP388176PZE
CSB-EP388176PZE
CSB-BP388176PZE
CSB-MP388176PZE
CSB-EP388176PZE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus NAD (P)H-quinone oxidoreductase subunit N CSB-YP388177PZE
CSB-EP388177PZE
CSB-BP388177PZE
CSB-MP388177PZE
CSB-EP388177PZE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Phosphoenolpyruvate carboxylase (ppc), partial CSB-YP388178PZE
CSB-EP388178PZE
CSB-BP388178PZE
CSB-MP388178PZE
CSB-EP388178PZE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus Lysine--tRNA ligase (lysS), partial CSB-YP388179PZE
CSB-EP388179PZE
CSB-BP388179PZE
CSB-MP388179PZE
CSB-EP388179PZE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>